Inarigivir Soproxil (GS-9992)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Inarigivir Soproxil (GS-9992), covering 2022-04-04 to 2022-04-04. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Antiviral Activity of Inarigivir Soproxil (Formerly: GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB) [Phase 2]